blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2313087

EP2313087 - PHARMACEUTICAL DOSAGE FORM FOR IMMEDIATE RELEASE OF AN INDOLINONE DERIVATIVE [Right-click to bookmark this link]
StatusPatent maintained as amended
Status updated on  20.10.2023
Database last updated on 16.05.2026
FormerThe patent has been granted
Status updated on  19.10.2018
FormerGrant of patent is intended
Status updated on  20.06.2018
FormerExamination is in progress
Status updated on  18.11.2016
Most recent event   Tooltip20.10.2023Patent maintained (B2 publication)published on 22.11.2023  [2023/47]
Applicant(s)For all designated states
Boehringer Ingelheim International GmbH
Binger Strasse 173
55216 Ingelheim am Rhein / DE
[2023/47]
Former [2018/47]For all designated states
Boehringer Ingelheim International GmbH
Binger Strasse 173
55216 Ingelheim am Rhein / DE
Former [2011/17]For all designated states
Boehringer Ingelheim International GmbH
Binger Strasse 173
55216 Ingelheim am Rhein / DE
Inventor(s)01 / MESSERSCHMID, Roman
Boehringer Ingelheim GmbH
CD Patents
Binger Str. 173
55216 Ingelheim Am Rhein / DE
02 / LACH, Peter
Boehringer Ingelheim GmbH
CD Patents
Binger Str. 173
55216 Ingelheim Am Rhein / DE
03 / SOKOLIESS, Torsten
Boehringer Ingelheim GmbH
CD Patents
Binger Str. 173
55216 Ingelheim Am Rhein / DE
04 / STOPFER, Peter
Boehringer Ingelheim GmbH
CD Patents
Binger Str. 173
55216 Ingelheim Am Rhein / DE
05 / TROMMESHAUSER, Dirk
Boehringer Ingelheim GmbH
CD Patents
Binger Str. 173
55216 Ingelheim Am Rhein / DE
 [2018/47]
Former [2011/17]01 / MESSERSCHMID, Roman
Boehringer Ingelheim GmbH CD Patents Binger Str. 173
55216 Ingelheim Am Rhein / DE
02 / LACH, Peter
Boehringer Ingelheim GmbH CD Patents Binger Str.173
55216 Ingelheim Am Rhein / DE
03 / SOKOLIESS, Torsten
Boehringer Ingelheim GmbH CD Patents Binger Str. 173
55216 Ingelheim Am Rhein / DE
04 / STOPFER, Peter
Boehringer Ingelheim GmbH CD Patents Binger Str. 173
55216 Ingelheim Am Rhein / DE
05 / TROMMESHAUSER, Dirk
Boehringer Ingelheim GmbH CD Patents Binger Str. 173
55216 Ingelheim Am Rhein / DE
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[2023/47]
Former [2012/40]Simon, Elke Anna Maria, et al
Boehringer Ingelheim GmbH
Binger Strasse 173
55216 Ingelheim am Rhein / DE
Former [2011/17]Hammann, Heinz
Boehringer Ingelheim GmbH CD-Patents Binger Straße 173
55216 Ingelheim am Rhein / DE
Application number, filing date09757601.104.06.2009
[2011/17]
WO2009EP56895
Priority number, dateEP2008015775006.06.2008         Original published format: EP 08157750
[2011/17]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009147220
Date:10.12.2009
Language:EN
[2009/50]
Type: A1 Application with search report 
No.:EP2313087
Date:27.04.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 10.12.2009 takes the place of the publication of the European patent application.
[2011/17]
Type: B1 Patent specification 
No.:EP2313087
Date:21.11.2018
Language:EN
[2018/47]
Type: B2 New European patent specification 
No.:EP2313087
Date:22.11.2023
Language:EN
[2023/47]
Search report(s)International search report - published on:EP10.12.2009
ClassificationIPC:A61K9/48, A61K9/10, A61K47/14, A61K47/24, A61K47/44, A61K31/404
[2011/17]
CPC:
A61K9/4858 (EP,US); A61K9/48 (KR); A61K31/496 (US);
A61B5/48 (US); A61K31/404 (EP,US); A61K47/14 (EP,KR,US);
A61K47/24 (EP,KR,US); A61K47/44 (EP,US); A61K9/0053 (US);
A61K9/10 (KR); A61K9/20 (KR); A61P21/00 (EP);
A61P35/00 (EP); A61P37/00 (EP); A61P43/00 (EP);
G09B19/00 (US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2018/47]
Former [2011/17]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesBA07.01.2011
RS07.01.2011
TitleGerman:PHARMAZEUTISCHE DOSIERUNGSFORM ZUR SCHNELLEN FREISETZUNG EINES INDOLINONDERIVATS[2011/17]
English:PHARMACEUTICAL DOSAGE FORM FOR IMMEDIATE RELEASE OF AN INDOLINONE DERIVATIVE[2011/17]
French:FORME POSOLOGIQUE PHARMACEUTIQUE POUR LIBÉRATION IMMÉDIATE DE DÉRIVÉ D'INDOLINONE[2011/17]
Entry into regional phase07.01.2011National basic fee paid 
07.01.2011Designation fee(s) paid 
07.01.2011Examination fee paid 
Examination procedure18.11.2010Amendment by applicant (claims and/or description)
07.01.2011Examination requested  [2011/17]
07.01.2013Despatch of a communication from the examining division (Time limit: M06)
23.08.2013Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
04.11.2013Reply to a communication from the examining division
09.05.2016Despatch of a communication from the examining division (Time limit: M06)
18.11.2016Reply to a communication from the examining division
05.01.2018Despatch of a communication from the examining division (Time limit: M04)
04.05.2018Reply to a communication from the examining division
21.06.2018Communication of intention to grant the patent
10.10.2018Fee for grant paid
10.10.2018Fee for publishing/printing paid
10.10.2018Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  07.01.2013
Opposition(s)Opponent(s)01  20.08.2019  26.08.2019  ADMISSIBLE
Teva Pharmaceutical Industries Ltd.
124 Dvora HaNevi'a St.
6944020 Tel Aviv / IL
Opponent's representative
Lederer & Keller Patentanwälte Partnerschaft mbB, et al, et al
Unsöldstraße 2
80538 München / DE
 02  20.08.2019  26.08.2019  ADMISSIBLE
Generics (U.K.) Limited
Building 4, Trident Place
Mosquito Way
Hatfield Herts AL 10 9UL / GB
Opponent's representative
Ter Meer Steinmeister & Partner
Patentanwälte mbB
Nymphenburger Straße 4
80335 München / DE
 03  20.08.2019  26.08.2019  ADMISSIBLE
Ter Meer Steinmeister & Partner Patentanwälte mbB
Nymphenburger Strasse 4
80335 München / DE
Opponent's representative
Ter Meer Steinmeister & Partner
Patentanwälte mbB
Nymphenburger Straße 4
80335 München / DE
 [2021/48]
Former [2021/03]
Opponent(s)01  20.08.2019  26.08.2019  ADMISSIBLE
Teva Pharmaceutical Industries Ltd
5 Basel Street
49131 Petach-Tikva / IL
Opponent's representative
Lederer & Keller Patentanwälte Partnerschaft mbB, et al, et al
Unsöldstraße 2
80538 München / DE
 02  20.08.2019  26.08.2019  ADMISSIBLE
Generics (U.K.) Limited
Building 4, Trident Place
Mosquito Way
Hatfield Herts AL 10 9UL / GB
Opponent's representative
Ter Meer Steinmeister & Partner
Patentanwälte mbB
Nymphenburger Straße 4
80335 München / DE
 03  20.08.2019  26.08.2019  ADMISSIBLE
Ter Meer Steinmeister & Partner Patentanwälte mbB
Nymphenburger Strasse 4
80335 München / DE
Opponent's representative
Ter Meer Steinmeister & Partner
Patentanwälte mbB
Nymphenburger Straße 4
80335 München / DE
Former [2019/39]
Opponent(s)01  20.08.2019    ADMISSIBLE
Teva Pharmaceutical Industries Ltd
5 Basel Street
49131 Petach-Tikva / IL
Opponent's representative
Teipel, Stephan, et al, et al
Lederer & Keller
Patentanwälte Partnerschaft mbB
Unsöldstrasse 2
80538 München / DE
 02  20.08.2019    ADMISSIBLE
Generics (U.K.) Limited
Building 4, Trident Place
Mosquito Way
Hatfield Herts AL 10 9UL / GB
Opponent's representative
Ter Meer Steinmeister & Partner
Patentanwälte mbB
Nymphenburger Straße 4
80335 München / DE
 03  20.08.2019    ADMISSIBLE
Ter Meer Steinmeister & Partner Patentanwälte mbB
Nymphenburger Strasse 4
80335 München / DE
Opponent's representative
Ter Meer Steinmeister & Partner
Patentanwälte mbB
Nymphenburger Straße 4
80335 München / DE
06.09.2019Invitation to proprietor to file observations on the notice of opposition
13.03.2020Reply of patent proprietor to notice(s) of opposition
12.03.2021Date of oral proceedings
06.04.2021Despatch of minutes of oral proceedings
15.06.2023Legal effect of interlocutory decision in opposition
28.06.2023Despatch of interlocutory decision in opposition
18.07.2023Despatch of communication that the patent will be maintained as amended
18.10.2023Fee for printing new specification paid
Appeal following opposition01.06.2021Appeal received No.  T0676/21
01.06.2021Payment of appeal fee
10.08.2021Statement of grounds filed
15.06.2023Result of appeal procedure: maintenance in amended form
28.06.2023Despatch of the decision of the Board of Appeal
28.05.2021Appeal received No.  T0676/21
28.05.2021Payment of appeal fee
09.08.2021Statement of grounds filed
15.06.2023Result of appeal procedure: maintenance in amended form
28.06.2023Despatch of the decision of the Board of Appeal
04.06.2021Appeal received No.  T0676/21
04.06.2021Payment of appeal fee
05.08.2021Statement of grounds filed
15.06.2023Result of appeal procedure: maintenance in amended form
28.06.2023Despatch of the decision of the Board of Appeal
15.06.2023Date of oral proceedings
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
04.11.2013Request for further processing filed
04.11.2013Full payment received (date of receipt of payment)
Request granted
12.03.2014Decision despatched
Fees paidRenewal fee
30.06.2011Renewal fee patent year 03
02.07.2012Renewal fee patent year 04
01.07.2013Renewal fee patent year 05
24.03.2014Renewal fee patent year 06
30.06.2015Renewal fee patent year 07
30.06.2016Renewal fee patent year 08
30.06.2017Renewal fee patent year 09
02.07.2018Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X] WO2007054551  (BOEHRINGER INGELHEIM INT et al.) [X] 1-19 * page 1, lines 4-14 * * page 21, lines 17-20 * * page 52, line 1 - page 55, line 9 * * page 59, lines 14,15 * * page 59 - page 60; example 8 * * page 61 - page 62; examples 11,12 * * page 63; example 14 *
 [X] WO2006018182  (BOEHRINGER INGELHEIM INT et al.) [X] 1-19 * page 1, line 4 - page 2, line 1 * * page 19, lines 14-18 * * page 29, line 21 - page 32, line 16 * * claims 1,10 *
 [DX] WO2006067165  (BOEHRINGER INGELHEIM INT et al.) [DX] 1-19 * page 91, line 14 - page 92, line 2 * * page 206, line 20 - page 207, line 10 * * page 208 - page 210; examples F2-F4 * * page 211 - page 212; example F6 *
 [DX] WO2004013099  (BOEHRINGER INGELHEIM PHARMA et al.) [DX] 1-19 * page 1, lines 7-10 * * page 11, lines 24-29 * * claims 1,6,10,12 *
 [DX] WO2004096224  (BOEHRINGER INGELHEIM INT et al.) [DX] 1-19 * page 1, lines 17-28 * * page 21, lines 5-18 * * page 22, line 20 - page 24, line 32 * * page 25, line 17 - page 33, line 15 * * page 59, line 18 - page 61, line 5 * * page 63, line 21 - page 68, line 22 * * claims 1,12,19-21,26,29,30 *
ExaminationWO2009147212
 WO2010081817
 WO2009147218
 WO2010103058
 WO2010130757
OppositionWO2009147212
 WO2004013099
 US4829057
 US2004176392
 US4829057
 US5916591
 US6762180
 WO2007054551
 US2004176392
 US4829057
 US5916591
 US6762180
 WO2007054551
   "Pharmaceutics - The science of dosage form design", 1998, CHURCHILL LIVINGSTONE, article M. E. AULTON: "Physicochemical principles of pharmaceuticals", pages: 18 - 36, XP055636205
   "The Theory and Practice of Industrial Pharmacy", 1986, article L. LACHMAN: "The Theory and Practice of Industrial Pharmacy", pages: 398 - 412, XP055636210
   W. FAHRIG, U ET AL., DIE KAPSEL - GRUNDLAGE, TECHNOLOGIE UND BIOPHARMAZIE EINER MODERNEN ARZNEIFORM, 1983, pages 60 - 63, XP055636214
   "Handbook of pharmaceutical excipients", 2006, PHARMACEUTICAL PRESS, article R. C. ROWE: "Lecithin", pages: 409 - 411, XP055636223
   ANONYMOUS: "CHMP Assessment report - Ofev", EUROPEAN MEDICINES AGENCY, 20 November 2014 (2014-11-20), pages 1 - 16, XP055636228
   "Pharmazeutische Technologie", 2006, Stuttgart, article R. VOIGT: "Chapter 5 and Chapter 11", pages: 158 - 166, 317-320, XP055636245
   "Pharmazeutische Technologie", 1991, Stuttgart, article SUCKER ET AL.: "BERSICHT BER WICHTIGE HILFSSTOFFE", pages: 201 - 206, XP055532053
   DAVID J HAUSS: "Oral lipid-based formulations", DRUGS AND PHARMACEUTICAL SCIENCES, vol. 170, 2007, pages 88, XP022211986

DOI:   http://dx.doi.org/10.1016/j.addr.2007.05.006
   "Protein based films and coatings", 2002, article GENNADIOS: "Chapter 16 - Soft Gelatin Capsules", pages: 393 - 443, XP055636270
   "Pharmazeutische Technologie", 2006, article R. VOIGT: "Chapter 5 and Chapter 11", pages: 158 - 166 ; 317-320, XP055636245
   "Pharmazeutische Technologie", 1991, Stuttgart, article SUCKER ET AL.: "ubersicht uber wichtige hilfsstoffe", pages: 201 - 206, XP055532053
   DAVID J HAUSS: "Oral lipid-based formulations", DRUGS AND PHARMACEUTICAL SCIENCES, vol. 170, 2007, pages 88, XP022211986

DOI:   http://dx.doi.org/10.1016/j.addr.2007.05.006
   "Protein based films and coatings", 2002, article GENNADIOS: "Chapter 16 - Soft Gelatin Capsules"", pages: 393 - 443, XP055636270
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.